Navigation Links
TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
Date:8/27/2007

- Tezampanel Development Targeting Chronic Pain Conditions; Compound

Currently in Phase IIb Clinical Trial for Acute Migraine -

LA JOLLA, Calif., Aug. 27 /PRNewswire-FirstCall/ -- TorreyPines Therapeutics, Inc. (Nasdaq: TPTX) today announced that it has initiated a Phase I multiple dose clinical trial to evaluate the safety, tolerability and pharmacokinetics of tezampanel given as a subcutaneous injection to healthy male and female volunteers once-daily for four consecutive days. Tezampanel, an AMPA/kainate (AK) receptor antagonist that selectively binds to certain AK receptors to potentially block the transmission of pain signals, has been administered in single doses to more than 300 patients and healthy adults. Data from this multiple dose trial will support the continued development of tezampanel for the treatment of migraine as well as allow TorreyPines to consider expanding the development of tezampanel into additional chronic pain conditions.

The double-blind, placebo-controlled, multiple-dose trial will be conducted at one center in the United States. Approximately 30 healthy male and female volunteers, between the ages of 21 and 55, will be enrolled in sequential, dose-escalating cohorts and receive once-daily subcutaneous doses of placebo or 40 mg, 70 mg or 100 mg of tezampanel for four consecutive days. These same dose strengths, given as a single dose subcutaneous injection, are currently being evaluated by TorreyPines in a Phase IIb clinical trial of tezampanel for acute migraine.

"We are pleased with our development progress for tezampanel," said Neil Kurtz, M.D., President and Chief Executive Officer of TorreyPines. "Our Phase IIb trial in migraine has completed enrollment
'/>"/>

SOURCE TorreyPines Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
4. GTC Biotherapeutics to Webcast Corporate Presentation at the C.E. Unterberg, Towbin Emerging Growth Life Opportunities Conference
5. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
6. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
7. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
8. Pieris Progresses Development of its Proprietary Biotherapeutics Platform: Successful Demonstration of Dual Targeting With Duocalin(R) Technology
9. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
10. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
11. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ILL,N.C.,Nov.25/PRNewswire/--CempraPharmaceuticals...ntandchiefexecutiveofficer,willpresentatthePiperJa...ecember1,2009,atTheNewYorkPalaceHotelinNewYorkCity...oleadingantibioticclinicalprogramsforthetreatmento...tCempraPharmaceuticals ,, Foundedin2006,Cempra...
(Date:11/25/2009)...NVIEW,Calif.,Nov.25/PRNewswire/-- ChemoCentryx,In...eCompany,sPROTECT-1(theProspectiveRandomizedOralTh...(TM)(CCX282-B)inpatientswithmoderate-to-severeCroh...lesafetyandtolerabilityprofile.Thestudydemonstrate...severityasdefinedasa70-pointdecreaseintheCrohn,sDi...
(Date:11/24/2009)...,Calif.,Nov.24/PRNewswire-FirstCall/--Vermillion,I...ditsPlanofReorganizationandDisclosureStatementtoda...rtfortheDistrictofDelaware.Ahearingtoconsiderappro...December8,2009,withthehearingontheconfirmationofth...fortheCompanytopayallclaimsinfull.ThePlanisexpecte...
Breaking Medicine Technology:ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Wyeth Announces Holder Right to Surrender Convertible Debentures 12653 1Wyeth Announces Holder Right to Surrender Convertible Debentures 12653 2Wyeth Announces Holder Right to Surrender Convertible Debentures 12653 3Wyeth Announces Holder Right to Surrender Convertible Debentures 12653 4Torn Surgical Gloves Put Patients at Risk for Infection 49069 1Torn Surgical Gloves Put Patients at Risk for Infection 49069 2Providing health insurance for US children would be cheaper than expected study says 49065 1Providing health insurance for US children would be cheaper than expected study says 49065 2
...NEW YORK, July 12, 2007 /PRNewswire-FirstCall/ -- ...ibb Company today,announced results from an open-l...s a taxane and carboplatin in the first-line,treat...CLC). The,study did not meet its primary endpoint ...an independent radiology review,committee (IRRC). ...
... Helen Londe, M.D. Contributing Editor , ,Ce...sease of the small intestine that is triggered in ...f the gluten-containing grains wheat, rye, barley,...sult from the activation of both a T-cell and B-ce...n, villous atrophy, and crypt hyperplasia, and is ...
Other Medicine Technology:Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 2Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 3Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 4Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 5Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 6Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 7Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 8Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 9Non-Invasive Diagnostic Tests for Celiac Disease 2Non-Invasive Diagnostic Tests for Celiac Disease 3
(Date:11/25/2009)...ntinelleMedicalInc.,aleadingmanufacturerofMagnetic...entificInc.,aleadingproviderofsoftwareenablingtech...t4DAdvancedVisualizationsoftware. ,, Thisinnova...tbasedmedicalimagingofferinginthemarket.CalgarySci...taccess-requiringnosoftwaredownload,andrunsonanyMa...
(Date:11/25/2009)...anksgivingmealswillbedeliveredtoapproximately1,000...aithInAction/VolunteerActionforAging,aprogramopera...Plan.Formorethan17yearstheseorganizationshavegathe...alstoseniorsinneedinLongBeach,Lakewood,SignalHill,..., "Ourwarmholidaymealsaredeliveredtopeoplewhohavem...
(Date:11/25/2009).../--TheBlackAIDSInstituterecentlyheldBoardofDirecto..., ThenewBoardMembersareahighlydiversegroupoflea...rnmenthealthprograms,editorial,andbusinessentrepre...backgroundsincludingbothheterosexualandgayBlackmen...ngmultipleagegroups. ,, (Photo: http://www.news...
(Date:11/25/2009)...dPressJoinEfforttoEducate ,, MEMPHIS,Tenn.,Nov...ipolarFoundationandtheMedicAlertFoundationreceivea...whichisnowbeingwidelyacceptedasapreventivehealthca...arFoundationreceivedaproclamationofendorsementviaF...ianaMitchLandrieu.TheNationalBipolarFoundationstat...
(Date:11/25/2009)...cally significant survival benefit from adjuvant t...R)-positive tumors had high levels of phosphorylat...according to a brief communication published onlin...er Institute . , Approximately 50% of breast car...udies have shown that ER-alpha S118-P is required ...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3
... the thickness of the grey matter in the cortical ...ed thinning// of cortical region of the brain. Mai...rain is necessary for the proper functioning of th...ive and emotional processing, the researchers repo...
...educe world energy demand should it evolve into a ...ibly by more than 1-million barrels a day//. Wo...ording to data issued by the US Energy Information...by well over 1-million barrels per day,” the US in...
... a Singaporean, who had a bone marrow transplant i...ant operation without taking drugs to prevent reje... kidney failure four years ago. Two years later, d... Department of Medicine (NUH), "MDS is a pre-leuke...
...d are advised to be consumed; in the same league a...rient supplements help fight cancer even though th...particularly when you want to sell nutrition suppl...ion, helped save his neighbor known as “D.H.” with...
...d of trauma care are very few compared to other me...are would help in improving emergency treatments a...f deaths caused by accidents//. More than 10,...s, writing in this week's BMJ, argue that there is...
...rnia are finding out a new theory on the formation...hich connect other brain regions forming a new pro...eet of around 10 billion neurons divided into dist...haped by the environment? The protomap and protoco...
Other Medicine News:Health News:Meditation Maintains And Thickens The Grey Matter Of The Brain 2Health News:Bird Flu Likely To Reduce World Energy Demand 2Health News:Medical Breakthrough - Kidney Transplant Recipient Survives Without Drugs 2Health News:Another Benefit For Human Health Attributed To Omega-3-Fats 2Health News:Scientists breaking theory of cortex formation 2
Ultrafin™ Stirrup
6"H Plexiglass Armshield
Armboards
3D/SwingerOperating Table Clamp
Medicine Products: